InVitro International
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IVRO research report →
Companywww.invitrointl.com
InVitro International develops test kits for non-animal testing in the United States and internationally. Its products include Irritection Assay System, an invitro test, which could be used to detect, rank, and predict the ocular and/or dermal irritation potential of cosmetics, consumer products, pharmaceuticals, and chemical raw materials; and Corrositex, an invitro test that determines chemical corrosivity. The company also provides customized technology services for Irritection Assay System installation and testing process, as well as independent testing laboratory services for irritancy and corrosivity testing requirements.
- CEO
- W. Richard Ulmer
- IPO
- 1991
- Employees
- 6
- HQ
- Placentia, CA, US
Price Chart
Valuation
- Market Cap
- $1.89M
- P/E
- 18.64
- P/S
- 2.28
- P/B
- 1.12
- EV/EBITDA
- 9.49
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 81.83%
- Op Margin
- 8.60%
- Net Margin
- 12.19%
- ROE
- 6.05%
- ROIC
- 3.57%
Growth & Income
- Revenue
- $878.94K · 8.34%
- Net Income
- $121.98K · 14.32%
- EPS
- $0.01 · 14.89%
- Op Income
- $87.02K
- FCF YoY
- -108.80%
Performance & Tape
- 52W High
- $0.16
- 52W Low
- $0.03
- 50D MA
- $0.08
- 200D MA
- $0.09
- Beta
- -0.75
- Avg Volume
- 18.21K
Get TickerSpark's AI analysis on IVRO
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our IVRO Coverage
We haven't published any research on IVRO yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate IVRO Report →